Introduction
More than 350 million people worldwide are infected with the hepatitis B virus (HBV), some of whom have developed hepatitis, cirrhosis and hepatocellular carcinoma (HCC) [1, 2] as a result. Many studies suggest that the HBV X protein (HBx), encoded by the X gene, has a crucial role in the development of HCC [3] . HBx can also affect transcription, cell growth and apoptosis [4] . HBx is a transcriptional activator that can interact with a wide variety of regulatory elements, such as AP-1, AP-2, NF-κB and cAMP response element binding. Cytosolic HBx also participates in a wide range of signal transduction pathways (for example, the Akt, Wnt/β-catenin, NF-κB, Janus kinase/signal transducer and activator transcription factor (JAK/STAT) and Ras/Raf-mitogenactivated protein kinase (MAPK) pathways) [5] [6] [7] [8] .
The MAPK family includes three distinct subfamilies: the extracellular signal-regulated protein kinases (ERKs), including ERK1 and ERK2, the stress-activated c-Jun N-terminal kinases and p38 kinase [9] . Activation of the MAPK cascade is necessary for cell growth and proliferation [10] . The MAPK family serves as a convergence point for intracellular signal transduction pathways (including coupling HBx cytoplasmic signaling to its gene expression program) and functions as a mediator of cel-lular responses to a variety of cellular stimuli [11, 12] . Constitutively active mutations in this pathway increase kinase activity and can lead to transformation [12] . It has been reported that NF-κB and AP-1 are downstream effectors of MAPK [13, 14] , and phosphorylated ERK1/2 (p-ERK1/2) is clearly upregulated by HBx in cancer tissues [7] .
Arachidonic acid (AA) is an important component of membrane phospholipids and can be liberated by phospholipase A2 (PLA2) activation. Three key classes of enzymes, cyclooxygenases (COX), lipoxygenases (LOX) and CPY450, can metabolize AA to produce biologically active eicosanoids, such as prostaglandins (PGs), thromboxanes, leukotrienes (LTs), hydroxyeicosatetraenoic acids and hydroperoxyeicosatetraenoic acids. These eicosanoids have a significant role in cancer cell growth [15] [16] [17] . The key enzymes cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX), which catalyze AA metabolism, are overexpressed during inflammation and multistage tumor progression in many neoplastic disorders, including lung, breast and pancreatic cancers. In HBVinfected HCC tissues, the HBx gene is responsible for the upregulation of COX-2 [18] [19] [20] . We have found that HBx was able to regulate many genes associated with signal transduction pathways, cell cycle, metabolism and proliferation, and this regulation may be involved in the carcinogenesis associated with HBV [21] . Furthermore, in certain contexts, stable HBx transfection resulted in a malignant phenotype in human liver L-O2 cells in vivo and in vitro [22] .
It has been reported that AA metabolites are involved in the regulation of numerous signaling pathways. However, whether they play a role in HBx-mediated proliferation remains unclear. We hypothesized that AA metabolism and p-ERK1/2 may contribute to HBx-mediated cell proliferation. Our findings here show that HBx enhances and maintains the proliferation of liver cells via a positive cascade loop involving AA metabolism and p-ERK1/2.
Results

HBx upregulates p-ERK1/2, COX-2 and 5-LOX
We evaluated the phosphorylation levels of MAPK family proteins (phospho-ERK1/2, phospho-p38 and phospho-JNK) and the expression levels of enzymes associated with AA metabolism in the liver cell line, L-O2, and the hepatoma cell line, H7402. To assess the role of HBx, we used cells that had been stably transfected with a plasmid containing the gene for HBx (L-O2-X and H7402-X) or with a control vector (L-O2-pcDNA3 and H7402-P). Western blot analysis showed that the level of p-ERK1/2 was significantly increased in L-O2-X cells relative to L-O2 or L-O2-pcDNA3 cells (Figure 1 ), but the levels of p-p38 and p-JNK (Thr183 and Tyr185) in L-O2-X cells were no different from those in control cells (Supplementary information, Figure S1A ). The levels of total ERK1/2, p38 and JNK were equivalent in L-O2-X and L-O2 cells or L-O2-pcDNA3 cells (Figure 1 ; Supplementary information, Figure S1A ). We observed the same results in the hepatoma cell line expressing HBx, H7402-X (Figure 1 ; Supplementary information, 
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npg Figure S1A ). Western blot analysis also showed that the expression levels of COX-2 and 5-LOX were higher in L-O2-X cells than those in L-O2 and L-O2-pcDNA3 cells ( Figure 1 ). Again, similar results were observed in the hepatoma H7402-X cells ( Figure 1 ). The protein expression levels of COX-1 and 12R-LOX in L-O2-X cells were similar to those in L-O2 and L-O2-pcDNA3 cells (data not shown). Downregulation of HBx by RNAi abolished the upregulation of p-ERK1/2, COX-2 and 5-LOX, but a control RNAi did not (Figure 1 ). These data further suggest that HBx is responsible for the upregulation of p-ERK1/2, COX-2 and 5-LOX.
COX and LOX contribute to the activation of ERK1/2
The ERK signaling cascade can be activated by a wide variety of receptors, including receptor tyrosine kinases (RTKs), G-protein-coupled receptors (GPCRs) and ion channels [23, 24] . Many studies have revealed that p-ERK1/2 can be activated by the Gi/o family of GPCRs [25] [26] [27] . AA metabolite release is a receptor-dependent event, requiring a transducing Gi/o protein to initiate phospholipid hydrolysis and release AA into the cytosol. To determine whether AA metabolites and Gi/o proteins are responsible for the activation of p-ERK1/2 cascades in HBx-expressing liver (or hepatoma) cells, we added inhibitors of COX (indomethacin, indo), LOX (NDGA) and Gi/o proteins (pertussis toxin, PTX) to L-O2-X cells. To rule out any cytotoxic effects mediated by these inhibitors, we performed a nitro blue tertrazolium (NBT) assay. None of the inhibitors used in our experiments, PTX, indo, NDGA and PD98059, demonstrated cytotoxicity at the doses used (Supplementary information, Figure S1B) , and they did not affect the expression levels of HBx, p-p38 and p-JNK in L-O2-X cells (Supplementary information, Figure S1C ). We found that PTX, indo and NDGA significantly attenuated the level of p-ERK1/2 in L-O2-X cells in a dose-and time-dependent manner, but the levels of total ERK1/2 were not changed ( Figure 2A) .
Next, we examined whether the HBx-mediated release of AA metabolites could affect liver cells by treating L-O2 cells with L-O2-X conditioned media (L-O2-X CM). Western blot analysis showed that both boiled and non-boiled L-O2-X CM strongly induced phosphorylation of ERK1/2 in L-O2 cells in a dose-dependent manner ( Figure 2B ). Boiling the media ruled out the possibility that proteins in the conditioned media have a role in the upregulation of p-ERK1/2. Control L-O2 CM did not alter the level of p-ERK1/2 in L-O2 cells (Supplementary information, Figure S1D ). Moreover, the upregulation of p-ERK1/2 in L-O2 cells in response to the L-O2-X CM Figure  2C ). Similar results were observed in the H7402 cell line using western blot analysis ( Figure 2D ). These results suggest that the release of AA metabolites mediated by HBx is responsible for the activation of ERK1/2 and that AA metabolism by COX and LOX is critical for this process. We conclude that HBx-mediated release of AA metabolites has an important role in the activation of ERK1/2 in liver cells.
Previous studies have shown that NF-κB and AP-1 are downstream effectors of ERK [13, 14] . To provide further evidence that AA metabolites are responsible for the activation of ERK1/2, we investigated the effects of L-O2-X CM on the transcriptional activities of NF-κB and AP-1 in L-O2 cells using a reporter gene assay. The results of this assay showed that the L-O2-X CM was able to enhance the transcriptional activities of NF-κB (**P = 0.000777, vs CM from mock or L-O2-pcDNA3 cells, Student's t-test) and AP-1 (**P = 0.008134, vs CM from mock or L-O2-pcDNA3 cells, Student's t-test). By contrast, L-O2 CM failed to enhance the transcriptional activities of NF-κB and AP-1. L-O2-X CM from cells pretreated with indo or NDGA (abbreviated as L-O2-X CM (indo) and L-O2-X CM (NDGA)) also did not enhance NF-κB or AP-1 activity ( Figure 3A) . Similar results were found using the hepatoma H7402 and H7402-X cells ( Figure 3A) .
A 5′-bromodeoxyuridine (BrdU) incorporation assay showed that the proliferation of L-O2-X cells was elevated relative to L-O2 cells (***P = 0.00067, Student's t-test), but this effect was abolished by pretreatment with 50 µM indo for 2 h (**P = 0.008052,
. Similar results were obtained using H7402 and H7402-X cells ( Figure 3B ). Cell proliferation was also assessed using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The MTT assay showed that the proliferation of L-O2-X cells was elevated relative to L-O2 cells (***P = 0.00248, Student's t-test), but this effect was abolished by pretreatment with 100 ng/ml PTX, 50 µM indo or 50 µM NDGA for 2 h (PTX: **P = 0.014652; indo: **P = 0.0180272; NDGA: **P = 0.018471, vs untreated L-O2-X cells,
. Similar results were obtained using H7402 and H7402-X cells ( Figure 3C ). Cell proliferation was also evaluated by flow cytometric analysis of the proportion of cells entering S phase (proliferation index (PI): P < 0.01, Student's t-test, Tables 1 and 2 ; Supplementary information, Figure S2 ). The data above suggest that COX-2 and 5-LOX are responsible for promoting the proliferation of L-O2-X (or H7402-X) cells.
Increased release of PGE2 and leukotriene B4 (LTB4) by HBx
To provide further support for the roles of AA metabolites in the activation of ERK1/2, we determined the amounts of PGE2 (a metabolite of COX-2) and LTB4 (a metabolite of 5-LOX) in the conditioned media of L-O2, L-O2-X, H7402 and H7402-X cells by enzyme-linked immunosorbent assay (ELISA). The amounts of PGE2 and LTB4 were higher in the conditioned media of L-O2-X cells than those in the conditioned media of L-O2 cells (PGE2: *P = 0.014277, LTB4: *P = 0.013927, vs L-O2 cells, Student's t-test). However, this elevation was abolished by pretreatment with indo or NDGA (PGE2: *P = 0.046421; LTB4: *P = 0.040811, vs untreated L-O2-X cells, Student's t-test). The amounts of PGE2 and LTB4 in the medium of L-O2 cells were also reduced when cells were treated with indo or NDGA. In addition, the 
-test).
Conditioned media from L-O2-X cells pretreated with 50 µM indo or 50 µM NDGA for 2 h (L-O2-X CM (indo or NDGA)) lost this activity (P < 0.01, Student's t-test). The same results were found in H7402-X cells. Data shown are from three independent experiments; error bars represent standard error of the mean or SEM. (B) BrdU incorporation assay showed that the proliferation of L-O2-X cells was greater than that of L-O2 cells (P < 0.01, Student's t-test). This was abolished by pretreatment with 50 µM indo for 2 h (P < 0.01, Student's t-test). L-O2-X CM promoted the growth of L-O2 cells (P < 0.05, Student's t-test), but conditioned medium from L-O2-X cells pretreated with 50 µM indo for 2 h (L-O2-X CM (indo)) did not (P < 0.05, Student's t-test). Similar results were obtained in H7402-X and H7402 cells. (C) MTT assay showed that the proliferation of L-O2-X cells was greater than that of L-O2 cells (P < 0.01, Student's t-test). This could be abolished by pretreatment with 100 ng/ml PTX, 50 µM indo or 50 µM NDGA for 2 h (P < 0.05, Student's t-test). L-O2-X CM promoted the growth of L-O2 cells (P < 0.05, Student's t-test), but conditioned media from L-O2-X cells pretreated with 50 µM indo for 2 h (L-O2-X CM (indo)) did not (P < 0.05, Student's t-test). Similar results were obtained in H7402 and H7402-X cells. Figure 4A ). Similar results were obtained using the hepatoma H7402 and H7402-X cells (P < 0.05, Student's t-test; Figure 4B ). Thus, our data support that released AA metabolites contribute to the activation of ERK1/2.
Upregulation of COX-2/5-LOX by exogenous AA and their roles in ERK1/2 activation
To further verify that COX-2 and 5-LOX were responsible for the activation of ERK1/2, we added exogenous AA to L-O2 (or H7402) cells. The addition of AA upregulated the expression levels of COX-2 and 5-LOX in a time-dependent manner. Meanwhile, the level of p-ERK1/2 was increased, but the level of total ERK1/2 was unaffected, as demonstrated by western blot analysis ( Figure 4C ). The activation of ERK1/2 in response to exogenous AA was abolished in a dose-dependent manner by pretreatment of cells with PTX ( Figure 4D ), indo or NDGA ( Figure 4E ), suggesting that Gi/o proteins, COX-2 and 5-LOX act as intermediates in the AA-mediated activation of ERK1/2. Finally, a BrdU incorporation assay showed that exogenous AA promoted the growth of L-O2 (or H7402) cells in a dose-dependent manner (*P < 0.05, Student's t-test; Figure 4F ). Our data suggest that the AA metabolites released via a COX-and LOX-dependent mechanism, rather than AA itself, are responsible for the activation of ERK1/2. Thus, we conclude that AA metabolism contributes to the HBx-mediated promotion of proliferation of liver cells through p-ERK1/2.
Activation of ERK1/2 contributes to the upregulation of cPLA2, COX-2 and 5-LOX
The data above suggest that a link between AA metabolism and p-ERK1/2 could contribute to the cell growth mediated by HBx. Next, we determined whether p-ERK1/2 contributes to the regulation of cPLA2, COX-2 and 5-LOX in L-O2-X and H7402-X cells. Reverse transcription-polymerase chain reaction (RT-PCR) showed that the expression levels of cPLA2, COX-2 and 5-LOX mRNA in L-O2-X (or H7402-X) cells were downregulated by treatment with 30 µM PD98059 (an inhibitor of MEK1, upstream of ERK; Figure 5A ). Western blot analysis showed that expression levels of cPLA2, COX-2 and 5-LOX proteins were also downregulated by PD98059 ( Figure 5B ). In addition, the amounts of PGE2 (a metabolite of COX-2) and LTB4 (a metabolite of 5-LOX) were decreased in the culture media from L-O2-X (or H7402-X) cells pretreated with 30 µM PD98059 (PGE2: *P = 0.029258; LTB4: *P = 0.047149, vs untreated L-O2-X cells, Student's t-test; Figure 5C ). Our findings suggest that activation of ERK1/2 contributes to the upregulation of cPLA2, COX-2 and 5-LOX, and that ERK1/2 activation can be sustained in a positive feedback loop through the upregulation of COX-2 and 5-LOX.
Discussion
Hepatitis B virus infection is a major global health issue. In particular, the HBx protein has a multifaceted role in the development of HCC, modulating signal transduction, cell-cycle progression, cell growth and apoptosis [4] . In this study, we have demonstrated that 
-test).
The data presented are from three independent experiments; error bars represent standard error. PTX (ng/ml): HBx enhances the proliferation of liver cells by a positive feedback loop involving AA metabolism by COX-2 and 5-LOX, ERK1/2 activation, released AA metabolites and Gi/o proteins. Our conclusions are consistent with previous results in which HBx induced proliferation in cultured cells [27] and another study in which HBx expression induced cell-cycle progression within the milieu of the regenerating liver [28] . The results of our study oppose the conclusions of other studies that showed that transient transfection of HBx induced apoptosis and that HBx inhibited hepatocyte regeneration [29] [30] [31] . The reasons behind this apparent discrepancy need to be further investigated. In addition, these disparities highlight the need for physiologically relevant cell models to clarify the role of HBx in apoptosis and cell proliferation. To better understand the physiological roles of HBx, it is worthwhile to strive for a better understanding of the signaling pathways associated with HBx-mediated cell growth. ERK-MAPK signaling has been clearly implicated in the regulation of liver cell proliferation [32, 33] . However, the molecular mechanism underlying the liver cell proliferation mediated by HBx remained unclear. In our previous study, we used a cDNA microarray to identify candidate target genes that were upregulated in L-O2-X and H7402-X cells [21, 34] . We found genes involved in MAPK and Wnt pathways and AA metabo- The ERK signaling cascade is a central MAPK pathway that plays a role in the regulation of various cellular processes such as proliferation, differentiation and cellcycle progression [35] [36] [37] . In this study, we focused on the roles of HBx in promoting liver cell growth via p-ERK1/2 and AA metabolite signaling pathways. Using the parallel L-O2-X and L-O2 (or L-O2-pcDNA3) cell lines, we observed that expression levels of COX-2 and 5-LOX were higher in the L-O2-X cells (Figure 1) . We also compared the levels of p-ERK1/2, p-p38 and p-JNK in L-O2-X and L-O2 (or L-O2-pcDNA3) cells. We found that the ERK signaling pathway was activated in L-O2-X cells (Figure 1 ). These data are consistent with the report that HBx can upregulate p-ERK1/2 in cancer tissues [7] . Our findings also suggested that AA metabolism might play an important role in the HBx-mediated proliferation of liver cells. Specifically, HBx may promote proliferation of liver cells by activating ERK1/2 and the p-ERK1/2 levels may be linked to AA metabolism.
The ERK signaling pathway is activated by a wide variety of receptors, including RTKs, GPCRs and ion channels [23] . It has been reported that Gi/o proteins, which are known to affect a variety of cellular functions, activate p-ERK1/2 and subsequent cell proliferation signals [10, 32] . AA metabolites are also able to induce cell growth and have been strongly implicated in tumor development [38, 39] . Exogenous AA and its lipid metabolites have been shown to induce ERK activation [40] . Several studies have demonstrated that specific inhibitors of COX and LOX reduce the incidence of development and metastasis of breast cancer tumors in animal models [41] [42] [43] [44] and in humans [43] . Furthermore, COX-2 inhibitors can inhibit the growth of HBx-positive HCC cells [45] . The p-ERK1/2 cascade is the major signaling pathway for both COX-2 upregulation and PG synthesis [46] . Accumulating evidence suggests that 5-LOX has a vital role in the development and progression of human cancers and interacts with multiple intracellular signaling pathways that control cancer cell proliferation. 5-LOX inhibitors can block the proliferation of cancer cells [47] . To identify the signal transduction pathways associated with HBx-mediated AA metabolism and activation of ERK1/2, we used inhibitors of COX, LOX and Gi/o proteins. Our data showed that the expression level of p-ERK1/2 was decreased by the inhibitors of these proteins (indo, NDGA and PTX; Figure 2A) . Therefore, our observations suggest that COX-2, 5-LOX and Gi/o proteins are upstream activators of p-ERK1/2.
We showed that both boiled and non-boiled conditioned media from L-O2-X cells were able to activate ERK1/2 ( Figure 2B, 2C and 2D) . Together with the data above, this suggested that HBx-mediated release of soluble AA metabolites is responsible for the activation of ERK1/2. Many studies have demonstrated that AA metabolites such as PGE2 and LTB4 have significant roles in cancer cell growth [15, 16] , so we determined the levels of these in the conditioned media of L-O2-X cells. ELISA results showed that the levels of PGE2 and LTB4 were higher in the conditioned media of L-O2-X (or H7402-X) cells than in that of L-O2 (or H7402) cells ( Figure 4A and 4B) . This finding strongly suggests that these released AA metabolites are responsible for the activation of ERK1/2 in L-O2 (or H7402) cells. Moreover, we found that exogenous AA upregulated the levels of COX-2, 5-LOX and p-ERK1/2 ( Figure 4C, 4D and 4E ) in L-O2 cells. The fact that the increase of p-ERK1/2 was sensitive to the inhibition of COX and LOX suggests that the release of AA metabolites via COX and LOX activity, rather than AA itself, activates ERK1/2. Overall, our findings indicate that HBx enhances the proliferation of liver cells through the activation of ERK1/2, with released AA metabolites acting as upstream activators. We hypothesized that activated ERK1/2 might upregulate the expression of COX-2 and 5-LOX to maintain the proliferation mediated by HBx and attempted to identify the effect of p-ERK1/2 on the regulation of cPLA2, COX-2 and 5-LOX. Interestingly, our results verified this hypothesis ( Figure 5 ), thus providing new insight into the mechanism of cell proliferation that is mediated by HBx.
Our findings are summarized in a model in Figure 6 . Constitutive expression of the HBx protein enhances and maintains the growth of liver cells by a positive feedback loop involving COX-2, 5-LOX, released AA metabolites, Gi/o proteins and p-ERK1/2. These findings enhance our understanding of the cell signaling pathways involved in HBV-related liver diseases and suggest potential therapies for these diseases, including perhaps the prevention of HCC.
Materials and Methods
Cell culture
L-O2 (a human immortalized liver cell line), L-O2-pcDNA3 (L-O2 stably transfected with the empty pcDNA3 plasmid) [48] and L-O2-X (L-O2 stably transfected with the pCMV-X plasmid, which contained the X gene cloned from the HBV genome, subtype ayw) [48] , H7402 (a human hepatoma cell line), H7402-P (H7402 stably transfected with the empty pcDNA3 plasmid), H7402-X (H7402 stably transfected with the pCMV-X plasmid) [34, 49] were maintained in RPMI Medium 1640 (Gibco, CA, USA) supplemented with heat-inactivated 10% fetal calf serum, 100 U/ml penicillin and 100 mg/ml streptomycin in a humidified atmosphere of 5% CO 2 and 95% air at 37 °C.
Treatment of cells with inhibitors
L-O2, L-O2-pcDNA3 and L-O2-X (or H7402, H7402-P and H7402-X) cells were cultured in six-well plates for 24 h as above, and then the cells were re-cultured in serum-free medium for 12 h. L-O2-X (or H7402-X) cells were treated with 50 ng/ml or 100 ng/ml PTX (an inhibitor of Gi/o proteins; List Biological Laboratories Inc., USA), 25 µM or 50 µM indo (an inhibitor of COX-2; Sigma-Aldrich, USA) or 25 µM or 50 µM NDGA (an inhibitor of 5-LOX; Sigma-Aldrich) for 1 or 2 h. L-O2 (or H7402 cells) were treated with 20 µM AA for 15, 30, 60 and 120 min. L-O2 (or H7402) cells were treated with PTX, indo or NDGA at the concentrations defined previously, followed by treatment with 20 µM AA for 2 h. In addition, L-O2-X (or H7402-X) cells were treated with 30 µM PD98059 (an inhibitor of MEK1; Sigma-Aldrich) for 4 h. In the experiments that used siRNA, the L-O2-X (or H7402-X) cells were co-transfected with a pSilencer-X vector that produces siRNA targeting HBx mRNA or negative control siRNA [34] .
The supernatants derived from the L-O2-X (or H7402-X) cell cultures, termed L-O2-X CM (or H7402-X CM), were harvested and stored at −80 °C until used as conditioned media for cell treatment. L-O2-X (or H7402-X) cells were pretreated by the inhibitors, 50 µM indo or 50 µM NDGA, for 2 h and were subsequently washed three times with fresh media and re-cultured in fresh media for 48 h. The supernatants, termed L-O2-X CM (indo) or L-O2-X CM (NDGA) or H7402-X CM (indo or NDGA), were harvested and stored until used as conditioned media. L-O2 (or H7402) cells were cultured for 48 h, followed by treatment with 50% or 100% L-O2-X CM (or H7402-X CM), boiled 50% or 100% L-O2-X CM (or H7402-X CM), termed L-O2-X BCM (or H7402-X BCM) and 50% or 100% L-O2-X CM (indo or NDGA) (or H7402-X CM (indo or NDGA)) for 12 h. The cells cultured with conditioned media were subjected to western blot analysis, luciferase reporter gene assays, flow cytometry analysis, ELISA and RT-PCR.
In addition, the cell culture supernatants of L-O2 cells, termed L-O2 CM, were harvested and stored at −80 °C until used as conditioned media. L-O2 cells were pretreated with 50% or 100% L-O2 CM for 12 h and 50 µM indo and 50 µM NDGA for 2 h before serum-free culture. The levels of p-ERK1/2 in the treated L-O2 cells were examined by western blot analysis.
Nitro blue tertrazolium assay
To examine the cytotoxicity of the tested inhibitors, L-O2 and L-O2-X cells were cultured in 96-well plates for 24 h as above, after which the cells were re-cultured in serum-free medium for 12 h. L-O2 and L-O2-X cells were treated for 2 h with PTX, indo, NDGA or PD98059 at the concentrations defined previously. Cytotoxicity was analyzed by the reduction of NBT (Sigma-Aldrich). Briefly, 0.75 µM NBT was added to the treated cells, which were then incubated at 37 °C for 1 h. Then, the absorbance was read with an ELISA reader system (Labsystem Multiskan Ascent) at 560 nm. The conditions of the NBT assay were as described by Wei et al. [50] .
Western blot analysis
The cells treated by the protocols above were washed three times with ice-cold PBS and total protein was extracted directly in lysis buffer. The experiment was performed as previously reported [34] . The primary antibodies used were anti-p-ERK1/2, antitotal-ERK1/2, anti-phosphorylated-JNK (p-JNK) (Cell Signaling Technology, USA), anti-cPLA2, anti-phosphorylated p38 (p-p38), anti-β-actin (Sigma-Aldrich), anti-HBx (Abcom, Cambridge, UK), anti-COX-2 and anti-5-LOX (NeoMarkers, USA). The membranes were washed three times in PBS with 0.1% Tween 20 and incubated for 1 h with secondary antibody (peroxidase-conjugated antirabbit or anti-mouse IgG). The membranes were then washed three times, and the bands were visualized using ECL reagent (Amersham Pharmacia Biotech, Milan, Italy).
Luciferase reporter gene assay
Cells were cultured in 24-well plates and transfected with reporter constructs (0.3 µg per well) using Lipofectamine 2000 reagent. The luciferase reporters used were as follows: pGL3-NF-κB, pGL3-AP-1, pGL3-basic, pGL3-control (0.3 µg per well) and the renilla luciferase reporter vector, pRL-TK. The luciferase reporter assay was performed according to the dual-luciferase reporter assay system (Promega) in L-O2, L-O2-pcDNA3 and L-O2-X (or H7402, H7402-P and H7402-X) cells using the above vectors and the pSilencer-X plasmid [34] . Luciferase activity was measured using FB12 Single Tube luminometer (Berthold Detection Systems GmbH, Germany). NF-κB or AP-1 promoter activity www.cell-research.com | Cell Research Changliang Shan et al. 573
npg was analyzed by detecting firefly luciferase activity and normalizing to renilla luciferase activity in each well (each assay was performed in triplicate) as previously described [48] .
BrdU incorporation assay
The BrdU (Sigma, St. Louis, MO, USA) incorporation assay is used to measure DNA synthesis, a sign of cell proliferation [51] . L-O2 and L-O2-X (or H7402 and H7402-X) cells were seeded in 24-well plates for 12 h and were serum starved in the defined media overnight. L-O2-X (or H7402-X) cells were treated with 100 ng/ml PTX for 2 h. L-O2 (or H7402) cells were treated with L-O2-X CM (or H7402-X CM) or L-O2-X CM (indo) (or H7402-X CM (indo)) for 12 h. L-O2 (or H7402) cells were treated with 5, 10, 20 µM AA for 2 h. The BrdU incorporation assay was performed as previously described [52] .
MTT assay
For the MTT (Sigma) assay, cells were incubated in 96-well plates at a density of 10 3 cells per well. After 48 h, 20 µl of 5 mg/ ml MTT was added to each well. After incubation at 37 °C for 4 h, the supernatants were removed carefully. Then 200 µl of dimethyl sulfoxide (Sigma) was added to each well and the wells were thoroughly mixed for 10 min. The absorbance value (OD) at 490 nm of each well was measured using an ELISA reader system (Labsystem Multiskan Ascent). All experiments were performed in triplicate.
Flow cytometry analysis
The treated cells described above (1 × 10 6 cells) were harvested by trypsinization and washed twice with PBS. After centrifugation, the cells were resuspended in 2 ml of 70% ethanol at 4 °C overnight. After rinsing twice with PBS, the fixed cells were resuspended in PBS containing 50 µg/ml RNaseA (Sigma) and incubated at 37 °C for 30 min. Propidium iodide solution was added at a concentration of 50 µg/ml. The stained cells were passed through a nylon-mesh sieve to remove cell clumps and were then analyzed by a FACScan flow cytometer (Becton Dickinson, San Jose, CA, USA); the results were analyzed using CellQuest software (Becton Dickinson). The cell PI was calculated as the sum of the S and G2/ M phase cells, expressed as a fraction of the total cell population (PI=((S+G2/M)/(G0/G1+S+G2/M))×100) [53] . The flow cytometry experiment was repeated three times.
Enzyme-linked immunosorbent assay
The amounts of PGE2 (a metabolite of COX-2) and LTB4 (a metabolite of 5-LOX) in 100 µl aliquots of media were determined using a commercially available assay (human PGE2 and LTB4 ELISA kit; ADL, USA) according to the manufacturer's instruction. Plates were read at 450 nm using an ELISA reader system (Labsystem Multiskan Ascent) and the concentrations of PGE2 and LTB4 were calculated from the standard curve. The concentrations of PGE2 and LTB4 were normalized to total protein. The protein concentrations in these extracts were determined using a standard protein assay (Bio-Rad Laboratories Inc., Hercules, CA, USA). 
